Literature DB >> 18177246

Specific polymorphisms in hepatitis C virus genotype 3 core protein associated with intracellular lipid accumulation.

Ravi Jhaveri1, John McHutchison, Keyur Patel, Guan Qiang, Anna Mae Diehl.   

Abstract

BACKGROUND: Steatosis is a common histological finding and a poor prognostic indicator in patients with hepatitis C virus (HCV) infection. In HCV genotype 3-infected patients, the etiology of steatosis appears to be closely correlated with unknown viral factors that increase intracellular lipid levels. We hypothesize that specific sequence polymorphisms in HCV genotype 3 core protein may be associated with hepatic intracellular lipid accumulation.
METHODS: Using selected serum samples from 8 HCV genotype 3-infected patients with or without steatosis, we sequenced the HCV core gene to identify candidate polymorphisms associated with increased intracellular lipid levels.
RESULTS: Two polymorphisms at positions 182 and 186 of the core protein correlated with the presence (P= .03) and absence (P= .005) of intrahepatic steatosis. Transfected liver cell lines expressing core protein with steatosis-associated polymorphisms had increased intracellular lipid levels compared with non-steatosis-associated core isolates, as measured by oil red O staining (P= .02). Site-specific mutagenesis performed at positions 182 and 186 in steatosis-associated core genes yielded proteins that had decreased intracellular lipid levels in transfected cells (P= .03).
CONCLUSIONS: We have identified polymorphisms in HCV core protein genotype 3 that produce increased intracellular lipid levels and thus may play a significant role in lipid metabolism or trafficking, contributing to steatosis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18177246      PMCID: PMC2441823          DOI: 10.1086/524846

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  43 in total

1.  Adenovirus-mediated transfer of the muscle glycogen phosphorylase gene into hepatocytes confers altered regulation of glycogen metabolism.

Authors:  A M Gómez-Foix; W S Coats; S Baqué; T Alam; R D Gerard; C B Newgard
Journal:  J Biol Chem       Date:  1992-12-15       Impact factor: 5.157

2.  Different mechanisms of steatosis in hepatitis C virus genotypes 1 and 3 infections.

Authors:  C Hézode; F Roudot-Thoraval; E-S Zafrani; D Dhumeaux; J-M Pawlotsky
Journal:  J Viral Hepat       Date:  2004-09       Impact factor: 3.728

3.  Liver fat-storing cell clones obtained from a CCl4-cirrhotic rat are heterogeneous with regard to proliferation, expression of extracellular matrix components, interleukin-6, and connexin 43.

Authors:  P Greenwel; J Rubin; M Schwartz; E L Hertzberg; M Rojkind
Journal:  Lab Invest       Date:  1993-08       Impact factor: 5.662

4.  Alcohol is an important co-factor for both steatosis and fibrosis in Northern Italian patients with chronic hepatitis C.

Authors:  Paolo Fabris; Annarosa Floreani; Antonio Carlotto; Maria Teresa Giordani; Vincenzo Baldo; Clara Stecca; Lorella Marchioro; Andrea Tramarin; Tosca Bertin; Francesco Negro; Fausto de Lalla
Journal:  J Hepatol       Date:  2004-10       Impact factor: 25.083

Review 5.  Hepatitis C and steatosis.

Authors:  Anouk Dev; Keyur Patel; John G McHutchison
Journal:  Clin Liver Dis       Date:  2004-11       Impact factor: 6.126

6.  Hepatic steatosis in hepatitis C virus genotype 3 infection: does it correlate with body mass index, fibrosis, and HCV risk factors?

Authors:  Pratima Sharma; Vijayan Balan; Jose Hernandez; Marianne Rosati; James Williams; Hector Rodriguez-Luna; Joan Schwartz; Edwyn Harrison; Monte Anderson; Thomas Byrne; Hugo E Vargas; David D Douglas; Jorge Rakela
Journal:  Dig Dis Sci       Date:  2004-01       Impact factor: 3.199

7.  Hepatic expression of malonyl-CoA decarboxylase reverses muscle, liver and whole-animal insulin resistance.

Authors:  Jie An; Deborah M Muoio; Masakazu Shiota; Yuka Fujimoto; Gary W Cline; Gerald I Shulman; Timothy R Koves; Robert Stevens; David Millington; Christopher B Newgard
Journal:  Nat Med       Date:  2004-02-08       Impact factor: 53.440

8.  The impact of steatosis on disease progression and early and sustained treatment response in chronic hepatitis C patients.

Authors:  Heather M Patton; Keyur Patel; Cynthia Behling; David Bylund; Lawrence M Blatt; Marc Vallée; Shanon Heaton; Andrew Conrad; Paul J Pockros; John G McHutchison
Journal:  J Hepatol       Date:  2004-03       Impact factor: 25.083

9.  Effect of antiviral treatment on evolution of liver steatosis in patients with chronic hepatitis C: indirect evidence of a role of hepatitis C virus genotype 3 in steatosis.

Authors:  L Castéra; C Hézode; F Roudot-Thoraval; I Lonjon; E-S Zafrani; J-M Pawlotsky; D Dhumeaux
Journal:  Gut       Date:  2004-03       Impact factor: 23.059

10.  Novel adenovirus component system that transfects cultured cardiac cells with high efficiency.

Authors:  T A Kohout; J J O'Brian; S T Gaa; W J Lederer; T B Rogers
Journal:  Circ Res       Date:  1996-06       Impact factor: 17.367

View more
  27 in total

1.  Structural analysis of hepatitis C virus core-E1 signal peptide and requirements for cleavage of the genotype 3a signal sequence by signal peptide peptidase.

Authors:  Verena Oehler; Ana Filipe; Roland Montserret; Daniel da Costa; Gaie Brown; François Penin; John McLauchlan
Journal:  J Virol       Date:  2012-05-16       Impact factor: 5.103

Review 2.  Unique ties between hepatitis C virus replication and intracellular lipids.

Authors:  Eva Herker; Melanie Ott
Journal:  Trends Endocrinol Metab       Date:  2011-04-15       Impact factor: 12.015

3.  Serum apolipoprotein C-III is independently associated with chronic hepatitis C infection and advanced fibrosis.

Authors:  J Rowell; A J Thompson; J R Guyton; X Q Lao; J G McHutchison; J J McCarthy; K Patel
Journal:  Hepatol Int       Date:  2011-07-07       Impact factor: 6.047

Review 4.  Genotype 3 Infection: The Last Stand of Hepatitis C Virus.

Authors:  Austin Chan; Keyur Patel; Susanna Naggie
Journal:  Drugs       Date:  2017-02       Impact factor: 9.546

5.  Hepatitis C virus core protein decreases lipid droplet turnover: a mechanism for core-induced steatosis.

Authors:  Charles Harris; Eva Herker; Robert V Farese; Melanie Ott
Journal:  J Biol Chem       Date:  2011-10-07       Impact factor: 5.157

Review 6.  Insulin resistance and liver steatosis in chronic hepatitis C infection genotype 3.

Authors:  Ludovico Abenavoli; Mario Masarone; Valentina Peta; Natasa Milic; Nazarii Kobyliak; Samir Rouabhia; Marcello Persico
Journal:  World J Gastroenterol       Date:  2014-11-07       Impact factor: 5.742

7.  Hepatic steatosis in hepatitis C is a storage disease due to HCV interaction with microsomal triglyceride transfer protein (MTP).

Authors:  Silvia Mirandola; David Bowman; Mahmood M Hussain; Alfredo Alberti
Journal:  Nutr Metab (Lond)       Date:  2010-02-23       Impact factor: 4.169

8.  Inhibition of core gene of HCV 3a genotype using synthetic and vector derived siRNAs.

Authors:  Saba Khaliq; Shah Jahan; Bushra Ijaz; Waqar Ahmad; Sultan Asad; Asim Pervaiz; Baila Samreen; Mahwish Khan; Sajida Hassan
Journal:  Virol J       Date:  2010-11-13       Impact factor: 4.099

Review 9.  Production and pathogenicity of hepatitis C virus core gene products.

Authors:  Hui-Chun Li; Hsin-Chieh Ma; Chee-Hing Yang; Shih-Yen Lo
Journal:  World J Gastroenterol       Date:  2014-06-21       Impact factor: 5.742

Review 10.  Steatosis and insulin resistance in hepatitis C: a way out for the virus?

Authors:  José A Del Campo; Manuel Romero-Gómez
Journal:  World J Gastroenterol       Date:  2009-10-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.